- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 171
Effect Photonics implements series C
Smile Invest and Innovation Industries Fund have co-led a $37m first tranche for TUe spinout Effect Photonics’ series C round.
Mar 18, 2021Amphista ties up $53m series B
Forbion and Gilde Healthcare have co-led a $53m series B round for Dundee spinout Amphista, which is working on targeted protein degradation technology.
Mar 18, 2021Rebike Mobility finishes series B cycle
Existing corporate investor Vorwerk Ventures contributed to an $11.9m round that will support the expansion of Rebike's e-bike rental service.
Mar 17, 2021Vaccitech accelerates to $168m series B
Tencent and Gilead Sciences took part in a round that will fund clinical trials for three of Vaccitech's vaccine product candidates.
Mar 17, 2021Davey leaves Barclays Ventures for SPAC life
Ben Davey has departed from corporate venturing activities at Barclays for an executive position at a special purpose acquisition company.
Mar 17, 2021Vaccitech gets $168m series B injection
The spinout’s technology was fundamental to Oxford’s covid vaccine, prompting OSI and Future Planet Capital to back a $168m round.
Mar 17, 2021Daily deal net: March 16, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Mar 16, 2021Alvotech amplifies private placement to $100m
Baxter Healthcare was among the investors in the $65m first close of a private placement the biosimilar drug developer has pushed to $100m.
Mar 16, 2021Skeleton Technologies powers up with $61m
The Harju Elekter-backed ultracapacitor producer will develop automated production technology with funding secured from the German government.
Mar 16, 2021Genesis cracks series B code with $45m
GV and Salesforce Ventures joined existing investor Citi in a $45m round for the financial application development platform.
Mar 16, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


